la clínica del hígado graso no alcohólico - Higadograso.org

16
another mechanism for drug-induced
steatosis in mice. Hepatology;38(1):133-
40. 2003.
19.Sanyal AJ, Contos MJ, Sterling RK,
Luketic VA, Shiffman ML, Stravitz RT,
Mills AS. Nonalcoholic fatty liver disease
in patients with hepatitis C is associated
with features of the metabolic syndrome.
Am J Gastroenterol. 98(9):2064-71.
2003.
20.Andrew J. Brown. Viral hepatitis and
fatty liver disease: how an unwelcome
guest makes pâté of the host. Biochem J.
416, e15-e17. 2008.
21.Paola Loria, Lucia Carulli, Marco
Bertolotti & Amedeo Lonardo. Endocrine
and liver interaction: the role of endocrine
pathways in NASH. Nature Reviews
Gastroenterology and Hepatology 6, 236-
247. 2009.
22.Noel M Lee, Carla W Brady.
Liver disease in pregnancy. World J
Gastroenterology 15(8):897-906. 2009.
23.Oo YH., Hubscher SG. and Adams DH.
Autoimmune hepatitis: new paradigms
in the pathogenesis, diagnosis, and
management. Hepatol Int. 4(2):475-93.
2010.
24.Weber RV, Buckley MC, Fried SK,
Kral JG. Subcutaneous lipectomy causes
a metabolic syndrome in hamsters. Am
J Physiol Regul Integr Comp Physiol.
279(3):R936-43. 2000.
25.Sanjay Agrawal , Herbert L
Bonkovsky. Management of nonalcoholic
steatohepatitis. J Clin Gastroenterol.
35(3):253-261. 2002.
26.Cotrim HP, Andrade ZA, Parana
R, Portugal M, Lyra LG, Freitas LA.
Nonalcoholic steatohepatitis: a toxic
liver disease in industrial workers. Liver.
19(4):299-304. 1999.
27.Dr. Alfredo Herrera González, Dr.
Alfredo Nasiff Hadad, Dr. Enrique Arus
Soler, Dr. Cosme Cand Huerta2 y Dra.
Nancy León. Hígado graso. Enfoque
diagnóstico y terapéutico. Revista Cubana
de Medicina 46 (1). 2007.
28.R. J. F. Loos and D. B. Savage.
Inherited susceptibility to non-alcoholic
fatty liver disease. Diabetologia 52:1000-
1002. 20009.
29.Qureshi K, Abrams GA. Metabolic
liver disease of obesity and role of adipose
tissue in the pathogenesis of nonalcoholic
fatty liver disease. World J Gastroenterol.
13(26):3540-3553. 2007.
30.Sreekumar R, Rosado B, Rasmussen
D, Charlton M. Hepatic gene expression
in histologically progressive nonalcoholic
steatohepatitis. Hepatology. 38(1):244-
51.2003.
31.Carulli L, Canedi I, Rondinella S,
Lombardini S, Ganazzi D, Fargion S,
De Palma M, Lonardo A, Ricchi M,
Bertolotti M, Carulli N, Loria P. Genetic
polymorphisms in non-alcoholic fatty
liver disease: interleukin-6-174G/C
polymorphism is associated with nonalcoholic
steatohepatitis. Dig Liver Dis.
41(11):823-8. 2009.
32.Yoneda M, Hotta K, Nozaki Y, Endo
H, Uchiyama T, Mawatari H, Iida H, Kato
S, Fujita K, Takahashi H, Kirikoshi H,
Kobayashi N, Inamori M, Abe Y, Kubota
K, Saito S, Maeyama S, Wada K, Nakajima
A. Association between angiotensin II
type 1 receptor polymorphisms and the
occurrence of nonalcoholic fatty liver
disease. Liver Int. 29(7):1078-85. 2009.
33.Sazci A, Akpinar G, Aygun C, Ergul
E, Senturk O and Hulagu S. Association
of Apolipoprotein E Polymorphisms
in Patients with Non-Alcoholic
Steatohepatitis. Dig dis Sci 53812):3218-
24. 2008.
34.Namikawa C, Shu-Ping Z, Vyselaar
JR, Nozaki Y, Nemoto Y, Ono M,
Akisawa N, Saibara T, Hiroi M, Enzan H,
Onishi S. Polymorphisms of microsomal
triglyceride transfer protein gene and
manganese superoxide dismutase gene in
non-alcoholic steatohepatitis. J Hepatol.
40(5):781-6. 2004.
35.Marko Duvnjak, Neven Baršic,
Vedran Tomašic, Ivan Lerotic. Genetic